<html xmlns="http://www.w3.org/1999/xhtml" xmlns:epub="http://www.idpf.org/2007/ops" xmlns:svg="http://www.w3.org/2000/svg" lang="en" xml:lang="en">
<head>
<title>5.2 Complementary Interactions between Proteins and Ligands: The Immune System and Immunoglobulins in Chapter 5 Protein Function</title>
<meta charset="utf-8"/>
<meta content="final" name="process"/>
<meta content="part" name="book_type"/>
<meta content="3.3" name="schema"/>
<link href="../styles/nel_9781319228002.css" rel="stylesheet" type="text/css"/>
<meta content="urn:uuid:e0000000-0000-0000-0000-000006631217" name="Adept.expected.resource"/>
</head>
<body class="bodymatter" epub:type="bodymatter">
<section class="sect1" id="dav_9781319322342_abxG5cTzrG">
<header id="dav_9781319322342_sDRHNuSgLR"><h3 class="a-head v1" id="dav_9781319322342_2AATAxmFYi">5.2 Complementary Interactions between Proteins and Ligands: The Immune System and Immunoglobulins</h3></header>
<p class="noindent" id="dav_9781319322342_hhAundb1wy">We have seen how the conformations of oxygen-binding proteins affect and are affected by the binding of small ligands (<span class="math" id="dav_9781319322342_qA55bMp2Gu" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><mrow><msub><mtext>O</mtext><mn>2</mn></msub></mrow></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper O Subscript 2" src="../images/MATH/nel_9781319228002_ch05_03EQ_0001.png"/></annotation-xml></semantics></math></span> or CO) to the heme group. However, most protein-ligand interactions do not involve a prosthetic group. <img alt="" aria-hidden="true" class="decorative size-large" id="dav_9781319322342_iFmE4aaeF7" role="presentation" src="../images/nelsonlehnpob8e_PG01b.png"/> Instead, the binding site for a ligand is more often like the hemoglobin binding site for BPG — a cleft in the protein lined with amino acid residues, arranged to make the binding interaction highly specific. Effective discrimination between ligands is the norm at binding sites, even when the ligands have only minor structural differences.</p>
<p class="indent" id="dav_9781319322342_pNbIZLDWUa">Almost all organisms have an immune system of some type that allows them to respond to challenges presented by environmental pathogens. The emergence of vertebrates about 500 million years ago was accompanied by the evolution of an adaptive immune system based on the generation of large numbers of distinct cell clones, each expressing a protein variant that could recognize and bind to a particular type of chemical structure. The system distinguishes molecular “self” from “nonself” and then destroys what is identified as nonself. In this way, the immune system eliminates viruses, bacteria, and other pathogens and molecules that may pose a threat to the organism. On a physiological level, the <dfn class="keyword" epub:type="keyword" id="dav_9781319322342_TrkN0144hn"><a class="glossref" epub:type="glossref" href="nel_9781319228002_EM_glossary.xhtml#dav_9781319322342_FXvud7z5uA" id="dav_9781319322342_ITy3Abuw0M" role="doc-glossref">immune response</a></dfn> is an intricate and coordinated set of interactions among many classes of proteins, molecules, and cell types. At the level of individual proteins, the immune response demonstrates how an acutely sensitive and specific biochemical system is built upon the reversible binding of ligands to proteins.</p>
<section class="sect2" id="dav_9781319322342_CwVYIcYXGZ">
<header id="dav_9781319322342_J3I5arV9dC"><h4 class="b-head v3" id="dav_9781319322342_FGwRZ6PIHo">The Immune Response Includes a Specialized Array of Cells and Proteins</h4></header>
<p class="noindent" id="dav_9781319322342_RGvH8W5VEo">Immunity is brought about by a variety of <dfn class="keyword" epub:type="keyword" id="dav_9781319322342_DHXRefL3sJ">leukocytes</dfn> (white blood cells), including <dfn class="keyword" epub:type="keyword" id="dav_9781319322342_PUSYHvAEzc">macrophages</dfn> and <dfn class="keyword" epub:type="keyword" id="dav_9781319322342_XPPSID7BxO"><a class="glossref" epub:type="glossref" href="nel_9781319228002_EM_glossary.xhtml#dav_9781319322342_yxdy34xyZR" id="dav_9781319322342_WA5pyyjedk" role="doc-glossref">lymphocytes</a></dfn>, all of which develop from undifferentiated stem cells in the bone marrow. Leukocytes can leave the bloodstream and patrol the tissues, each cell producing one or more proteins capable of recognizing and binding to molecules that might signal an infection.</p>
<p class="indent" id="dav_9781319322342_UlPy8wo7Ad">The immune response consists of two complementary systems, the humoral and cellular immune systems. The <dfn class="keyword" epub:type="keyword" id="dav_9781319322342_W0V20nsFJb">humoral immune system</dfn> (Latin <i class="semantic-i" id="dav_9781319322342_HK5emOp3ZJ">humor</i>, “fluid”) is directed at bacterial infections and extracellular viruses <span aria-label="165" epub:type="pagebreak" id="page165" role="doc-pagebreak"/>(those found in the body fluids), but it can also respond to individual foreign proteins. The <dfn class="keyword" epub:type="keyword" id="dav_9781319322342_MV0PRbAQjL">cellular immune system</dfn> destroys host cells infected by viruses and also destroys some parasites and foreign tissues.</p>
<p class="indent" id="dav_9781319322342_PAATrveDYL">At the heart of the humoral immune response are soluble proteins called <dfn class="keyword" epub:type="keyword" id="dav_9781319322342_Fd5CcKQaLT"><a class="glossref" epub:type="glossref" href="nel_9781319228002_EM_glossary.xhtml#dav_9781319322342_bXn6Lvjwid" id="dav_9781319322342_HUIr1AzGKp" role="doc-glossref">antibodies</a></dfn> or <dfn class="keyword" epub:type="keyword" id="dav_9781319322342_nbWxWHJMmr"><a class="glossref" epub:type="glossref" href="nel_9781319228002_EM_glossary.xhtml#dav_9781319322342_2VvjN3D3rC" id="dav_9781319322342_9mEND8qYcH" role="doc-glossref">immunoglobulins</a></dfn>, often abbreviated <dfn class="keyword" epub:type="keyword" id="dav_9781319322342_VZEZEusJsq">Ig</dfn>. Immunoglobulins bind bacteria, viruses, or large molecules identified as foreign and target them for destruction. Making up 20% of blood protein, the immunoglobulins are produced by <dfn class="keyword" epub:type="keyword" id="dav_9781319322342_v8s9Y4R7g4"><a class="glossref" epub:type="glossref" href="nel_9781319228002_EM_glossary.xhtml#dav_9781319322342_ZnTeAQ4YDj" id="dav_9781319322342_BEoUjVQuns" role="doc-glossref">B lymphocytes</a></dfn>, or <dfn class="keyword" epub:type="keyword" id="dav_9781319322342_Kb3D3X6wt1">B cells</dfn>, so named because they complete their development in the <i class="semantic-i" id="dav_9781319322342_PzTvwBt4p8">b</i>one marrow.</p>
<p class="indent" id="dav_9781319322342_RSiHFRbkfi">The agents at the heart of the cellular immune response are a class of <dfn class="keyword" epub:type="keyword" id="dav_9781319322342_dxVAgUEpGA"><a class="glossref" epub:type="glossref" href="nel_9781319228002_EM_glossary.xhtml#dav_9781319322342_o49OsYrXfb" id="dav_9781319322342_yUdOPBksYi" role="doc-glossref">T lymphocytes</a></dfn>, or <dfn class="keyword" epub:type="keyword" id="dav_9781319322342_2mEPassVxM">T cells</dfn> (so called because the latter stages of their development occur in the <i class="semantic-i" id="dav_9781319322342_mlQLoRdSPb">t</i>hymus), known as <strong class="important" id="dav_9781319322342_wDYpawe4sD">cytotoxic T cells</strong> (<span class="math" id="dav_9781319322342_6iWxQrtGZn" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><mrow><msub><mrow><mtext mathvariant="bold">T</mtext></mrow><mtext mathvariant="bold">C</mtext></msub></mrow></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="bold upper T Subscript bold upper C" src="../images/MATH/nel_9781319228002_ch05_03EQ_0002.png"/></annotation-xml></semantics></math></span><strong class="important" id="dav_9781319322342_1isuOME2Zx"> cells</strong>, also called killer T cells). Recognition of infected cells or parasites involves proteins called <dfn class="keyword" epub:type="keyword" id="dav_9781319322342_Y2cmlYXPfd">T-cell receptors</dfn> on the surface of <span class="math" id="dav_9781319322342_NY3tfDZSux" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><mrow><msub><mtext>T</mtext><mtext>C</mtext></msub></mrow></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper T Subscript upper C" src="../images/MATH/nel_9781319228002_ch05_03EQ_0003.png"/></annotation-xml></semantics></math></span> cells. Receptors are proteins, usually found on the outer surface of cells and extending through the plasma membrane, that recognize and bind extracellular ligands, thus triggering changes inside the cell.</p>
<p class="indent" id="dav_9781319322342_X6s1KNL4bY">In addition to cytotoxic T cells, there are <dfn class="keyword" epub:type="keyword" id="dav_9781319322342_sMEufEGaMs">helper T cells (<span class="math" id="dav_9781319322342_3e1laCPyOK" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><mrow><msub><mtext mathvariant="bold">T</mtext><mtext mathvariant="bold">H</mtext></msub></mrow></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="bold upper T Subscript bold upper H" src="../images/MATH/nel_9781319228002_ch05_03EQ_0004.png"/></annotation-xml></semantics></math></span> cells)</dfn>, whose function it is to produce soluble signaling proteins called cytokines, which include the interleukins. <span class="math" id="dav_9781319322342_ml729r9Kb7" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><mrow><msub><mtext>T</mtext><mtext>H</mtext></msub></mrow></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper T Subscript upper H" src="../images/MATH/nel_9781319228002_ch05_03EQ_0005.png"/></annotation-xml></semantics></math></span> cells interact with macrophages. The <span class="math" id="dav_9781319322342_MtdQlBU8Na" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><mrow><msub><mtext>T</mtext><mtext>H</mtext></msub></mrow></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper T Subscript upper H" src="../images/MATH/nel_9781319228002_ch05_03EQ_0006.png"/></annotation-xml></semantics></math></span> cells participate only indirectly in the destruction of infected cells and pathogens, stimulating the selective proliferation of those <span class="math" id="dav_9781319322342_xpGC4jFGrH" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><mrow><msub><mtext>T</mtext><mtext>C</mtext></msub></mrow></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper T Subscript upper C" src="../images/MATH/nel_9781319228002_ch05_03EQ_0007.png"/></annotation-xml></semantics></math></span> and B cells that can bind to a particular antigen. This process, called <dfn class="keyword" epub:type="keyword" id="dav_9781319322342_yNP0bGecUo">clonal selection</dfn>, increases the number of immune system cells that can respond to a particular pathogen. A host organism needs time, often days, to mount an immune response against a new antigen, but <dfn class="keyword" epub:type="keyword" id="dav_9781319322342_5vyeg9AKA9">memory cells</dfn> permit a rapid response to pathogens previously encountered. A vaccine to protect against a particular viral infection often consists of weakened or killed virus or isolated proteins from a viral or bacterial protein coat. When injected into a person, the vaccine generally does not cause an infection and illness, but it effectively “teaches” the immune system what the viral particles look like, stimulating the production of memory cells. On subsequent infection, these cells can bind to the virus and trigger a rapid immune response.</p>
<p class="indent" id="dav_9781319322342_ihkeMxe5yq">The importance of <span class="math" id="dav_9781319322342_m2T39zdNfe" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><mrow><msub><mtext>T</mtext><mtext>H</mtext></msub></mrow></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper T Subscript upper H" src="../images/MATH/nel_9781319228002_ch05_03EQ_0008.png"/></annotation-xml></semantics></math></span> cells is dramatically illustrated by the epidemic produced by HIV (human immunodeficiency virus), the virus that causes AIDS (acquired immune deficiency syndrome). <span class="math" id="dav_9781319322342_WhNZFCq2Wu" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><mrow><msub><mtext>T</mtext><mtext>H</mtext></msub></mrow></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper T Subscript upper H" src="../images/MATH/nel_9781319228002_ch05_03EQ_0009.png"/></annotation-xml></semantics></math></span> cells are the primary targets of HIV infection; elimination of these cells progressively incapacitates the entire immune system.</p>
<p class="indent" id="dav_9781319322342_iuGSZQ2bNd"><img alt="" aria-hidden="true" class="decorative size-large" id="dav_9781319322342_2Je4BDb5Fg" role="presentation" src="../images/nelsonlehnpob8e_PG01a.png"/> Each recognition protein of the immune system, either a T-cell receptor or an antibody produced by a B cell, specifically binds some particular chemical structure, distinguishing it from virtually all others. Humans are capable of producing more than <span class="math" id="dav_9781319322342_wn5WNA4U8K" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><mrow><msup><mrow><mn>10</mn></mrow><mn>8</mn></msup></mrow></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="10 Superscript 8" src="../images/MATH/nel_9781319228002_ch05_03EQ_0010.png"/></annotation-xml></semantics></math></span> different antibodies with distinct binding specificities. Given this extraordinary diversity, any chemical structure on the surface of a virus or an invading cell will most likely be recognized and bound by one or more antibodies. Antibody diversity is derived from random reassembly of a set of immunoglobulin gene segments through genetic recombination mechanisms that are discussed in <a class="crossref" href="nel_9781319228002_ch25_04.xhtml#dav_9781319322342_LJ88ml1S87" id="dav_9781319322342_HMJDHrWBES">Chapter 25 (see Fig. 25-42)</a>.</p>
<p class="indent" id="dav_9781319322342_6BzCMNDiXC">A specialized lexicon is used to describe the unique interactions between antibodies or T-cell receptors and the molecules they bind. Any molecule or pathogen capable of eliciting an immune response is called an <dfn class="keyword" epub:type="keyword" id="dav_9781319322342_0UWfyvZkFY"><a class="glossref" epub:type="glossref" href="nel_9781319228002_EM_glossary.xhtml#dav_9781319322342_8dj5ANLBsp" id="dav_9781319322342_mHCD5PAaWK" role="doc-glossref">antigen</a></dfn>. An antigen may be a virus, a bacterial cell wall, or an individual protein or other macromolecule. A complex antigen may be bound by several different antibodies. An individual antibody or T-cell receptor binds only a particular molecular structure within the antigen, called its <strong class="important" id="dav_9781319322342_ha0mKuo2Jz">antigenic determinant</strong> or <dfn class="keyword" epub:type="keyword" id="dav_9781319322342_wlx6kmp3FM"><a class="glossref" epub:type="glossref" href="nel_9781319228002_EM_glossary.xhtml#dav_9781319322342_FpRYSC5ns7" id="dav_9781319322342_2bwf6Yzv6x" role="doc-glossref">epitope</a></dfn>.</p>
<p class="indent" id="dav_9781319322342_N3WNUpua4D">It would be unproductive for the immune system to respond to small molecules that are common intermediates and products of cellular metabolism. Molecules of <span class="math" id="dav_9781319322342_GwaF1AK6Ti" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><mrow><msub><mi>M</mi><mtext>r</mtext></msub><mo>&lt;</mo><mn>5,000</mn></mrow></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper M Subscript r Baseline less-than 5,000" src="../images/MATH/nel_9781319228002_ch05_03EQ_0011.png"/></annotation-xml></semantics></math></span> are generally not antigenic. However, when small molecules are covalently attached to large proteins in the laboratory, they can be used to elicit an immune response. These small molecules are called <dfn class="keyword" epub:type="keyword" id="dav_9781319322342_Z64JiFelPl"><a class="glossref" epub:type="glossref" href="nel_9781319228002_EM_glossary.xhtml#dav_9781319322342_ksXrj1SUXV" id="dav_9781319322342_vswMm3ZjLu" role="doc-glossref">haptens</a></dfn>. The antibodies produced in response to protein-linked haptens will then bind to the same small molecules in their free form. Such antibodies are sometimes used in the development of analytical tests described later in this chapter or as a specific ligand in affinity chromatography (see <a class="crossref" href="nel_9781319228002_ch03_04.xhtml#dav_9781319322342_6hpiJ5l8On" id="dav_9781319322342_sPzBF5BqO6">Fig. 3-17c</a>). We now turn to a more detailed description of antibodies and their binding properties.</p>
</section>
<section class="sect2" id="dav_9781319322342_O3cn7gyM5P">
<header id="dav_9781319322342_KJVjIOAXSy"><h4 class="b-head v3" id="dav_9781319322342_b1UYqK72EM">Antibodies Have Two Identical Antigen-Binding Sites</h4></header>
<p class="noindent" id="dav_9781319322342_Eo6j72QIfF"><dfn class="keyword" epub:type="keyword" id="dav_9781319322342_4MNwjjtPtr">Immunoglobulin G (IgG)</dfn> is the major class of antibody molecule and one of the most abundant proteins in the blood serum. IgG has four polypeptide chains: two large ones, called heavy chains, and two smaller ones, called light chains, linked by noncovalent and disulfide bonds into a complex of <span class="math" id="dav_9781319322342_4d7QunINxW" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><mrow><msub><mi>M</mi><mtext>r</mtext></msub></mrow></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper M Subscript r" src="../images/MATH/nel_9781319228002_ch05_03EQ_0012.png"/></annotation-xml></semantics></math></span> 150,000. The heavy chains of an IgG molecule interact at one end, then branch to interact separately with the light chains, forming a Y-shaped molecule (<strong class="important" id="dav_9781319322342_J6ISLWcbLg"><a class="crossref" href="nel_9781319228002_ch05_03.xhtml#dav_9781319322342_TRdSyyMXTE" id="dav_9781319322342_yriN3YNXfG">Fig. 5-20</a></strong>). At the “hinges” separating the base of an IgG molecule from its branches, the immunoglobulin can be cleaved with proteases. Cleavage with the protease papain liberates the basal fragment, called <dfn class="keyword" epub:type="keyword" id="dav_9781319322342_QR9Mh0QQok">Fc</dfn> because it usually <i class="semantic-i" id="dav_9781319322342_TCLSvyEvkW">c</i>rystallizes readily, and the two branches, called <dfn class="keyword" epub:type="keyword" id="dav_9781319322342_HSEMtduUm6">Fab</dfn>, the <i class="semantic-i" id="dav_9781319322342_ak7rGswvbk">a</i>ntigen-<i class="semantic-i" id="dav_9781319322342_GVm1Xvg0R4">b</i>inding fragments. Each branch has a single antigen-binding site.</p>
<figure class="figure lm_img_lightbox num c4 center" id="dav_9781319322342_TRdSyyMXTE">
<img alt="A two-part figure, a and b, shows the structure of immunoglobulin G using shapes in part a and a ribbon structure in part b." aria-describedby="dav_9781319322342_TfXYYKwJqz" class="figure" id="dav_9781319322342_6v4SK84TMD" src="../images/nelsonlehnpob8e_05_20_288592.png"/>
<figcaption id="dav_9781319322342_CJUzPm5dox">
<p class="noindent" id="dav_9781319322342_w4DSMSHPsH"><span class="label" epub:type="label" id="dav_9781319322342_f9b6OLr3Qp">FIGURE </span><span class="ordinal" epub:type="ordinal" id="dav_9781319322342_0XNO2KxdCM">5-20 </span><span class="title" id="dav_9781319322342_298WHBrLGs">Immunoglobulin G. </span>(a) Pairs of heavy and light chains combine to form a Y-shaped molecule. Two antigen-binding sites are formed by the combination of variable domains from one light (<span class="math" id="dav_9781319322342_0P0EX27nlE" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><mrow><msub><mtext>V</mtext><mtext>L</mtext></msub></mrow></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper V Subscript upper L" src="../images/MATH/nel_9781319228002_ch05_03EQ_0013.png"/></annotation-xml></semantics></math></span>) chain and one heavy (<span class="math" id="dav_9781319322342_vBWz79QpqB" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><mrow><msub><mtext>V</mtext><mtext>H</mtext></msub></mrow></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper V Subscript upper H" src="../images/MATH/nel_9781319228002_ch05_03EQ_0014.png"/></annotation-xml></semantics></math></span>) chain. Cleavage with papain separates the Fab and Fc portions of the protein in the hinge region. The Fc portion also contains bound carbohydrate (shown in (b)). (b) A ribbon model of an IgG molecule. Although the molecule has two identical heavy chains (two shades of blue) and two identical light chains (two shades of red), it crystallized in the asymmetric conformation shown here. Conformational flexibility is important to the function of immunoglobulins. [(b) Data from PDB ID 1IGT, L. J. Harris et al., <i class="semantic-i" id="dav_9781319322342_U4MgfGBPYM">Biochemistry</i> 36:1581, 1997.]</p>
</figcaption>
</figure>
<aside class="hidden" id="dav_9781319322342_TfXYYKwJqz" title="hidden">
<p class="noindent" id="dav_9781319322342_cJsyR0M8o8">Part a shows a Y-shaped structure. C is the constant domain, V is the variable domain, and H, L refers to the heavy and light chains, respectively. The stem of the Y has two light blue left-hand vertical boxes and two blue right-hand vertical boxes. Together, these are labeled, F C. The top boxes are each labeled, C subscript uppercase H 2 and the bottom boxes are each labeled, C subscript uppercase H 3. The bottom boxes each have C O O minus extending from the bottom and a line connecting them to the top box above them. Each top box has a zig-zag line extending upward. Two rows labeled S bonded to S join the zig-zag on the left with the zig-zag on the right. These are labeled papain cleavage sites. The left-hand zig-zag bonds to the base of the left-hand fork of the Y, a light blue box labeled, C subscript uppercase H 1. This is the upper of two parallel rows of boxes. It is bonded to another light blue box above labeled V subscript uppercase H with two squares cut out of its top left side and N H 3 superscript plus extending from its top. The bottom box is also bonded by S bonded to S to a pink box labeled, C subscript uppercase L, which is the base of the parallel row of boxes to the left. This pink box has C O O minus extending below and is bonded to a box labeled, V subscript uppercase L above, which has two triangular cutouts at its top right and N H 3 plus extending above it. The entire fork region of the Y is labeled, uppercase F lowercase A lowercase B and the space between the two rows of boxes is labeled, antigen binding site. The right-hand fork of the Y is similar but inverse and the boxes are colored differently. Part b shows a ribbon structure with the same general shape. There is a blue rectangle at the bottom connected by strands to two blocks on the left and right above that each contain two different colors of material. A yellow roughly rectangular structure labeled, bound carbohydrate is visible near the top of the center bottom portion before strands extend out to the left and right.</p>
</aside>
<p class="indent" id="dav_9781319322342_lCVF7wCkZR">The fundamental structure of immunoglobulins was first established by Gerald Edelman and Rodney Porter in the 1960s. Each chain is made up of identifiable domains. Some are constant in sequence and structure from one IgG to the next; others are variable. The constant domains have a characteristic structure known as the <dfn class="keyword" epub:type="keyword" id="dav_9781319322342_1SZ8kPeybW">immunoglobulin fold</dfn>, a well-conserved structural motif in the all-<i class="semantic-i" id="dav_9781319322342_dHyqYKbOZO">β</i> class of proteins (<a class="crossref" href="nel_9781319228002_ch04_01.xhtml#dav_9781319322342_h2H1GbPZdU" id="dav_9781319322342_t20q1QTSq2">Chapter 4</a>). There are three of these constant domains in each heavy chain and one in <span aria-label="166" epub:type="pagebreak" id="page166" role="doc-pagebreak"/>each light chain. The heavy and light chains also have one variable domain each, in which most of the variability in amino acid sequence is found. The variable domains associate to create the antigen-binding site (<a class="crossref" href="nel_9781319228002_ch05_03.xhtml#dav_9781319322342_TRdSyyMXTE" id="dav_9781319322342_IMj97UkUNB">Fig. 5-20</a>), allowing formation of an antigen-antibody complex (<strong class="important" id="dav_9781319322342_mOx2veD4gX"><a class="crossref" href="nel_9781319228002_ch05_03.xhtml#dav_9781319322342_wWHIO1XZTD" id="dav_9781319322342_UoULXyr8G4">Fig. 5-21</a></strong>).</p>
<figure class="figure lm_img_lightbox num c3 main-flow" id="dav_9781319322342_wWHIO1XZTD">
<img alt="A figure shows how immunoglobulin G binds to an antigen by showing how the antibody joins with an antigen to form the antigen-antibody complex." aria-describedby="dav_9781319322342_7gk169dz6D" class="figure" id="dav_9781319322342_ZRBX1e5yvn" src="../images/nelsonlehnpob8e_05_21_288593.png"/>
<figcaption id="dav_9781319322342_Nob3HTr8L8">
<p class="noindent" id="dav_9781319322342_2MNjF0HoO3"><span class="label" epub:type="label" id="dav_9781319322342_QeLcxDnwji">FIGURE </span><span class="ordinal" epub:type="ordinal" id="dav_9781319322342_3tdTQHkdBu">5-21 </span><span class="title" id="dav_9781319322342_9oOkaNDSSB">Binding of IgG to an antigen. </span>To generate an optimal fit for the antigen, the binding sites of IgG often undergo slight conformational changes. Such induced fit is common to many protein-ligand interactions.</p>
</figcaption>
</figure>
<aside class="hidden" id="dav_9781319322342_7gk169dz6D" title="hidden">
<p class="noindent" id="dav_9781319322342_6uo2F98t2x">An antibody is shown as a Y-shaped structure with two strands that run parallel and then separate to left and right to form a fork before each ends with a triangular cutout on top. Where they separate, two horizontal bands connect the halves. To the sides of this region, two similar bands extend out (one to the left and one to the right), and each angles slightly downward to join with a bar that runs parallel to the main fork. Each of these outer bars of the fork has a triangular cutout at its top end. On left and right, the open areas between the two bars that form each side of the fork are labeled, antigen-binding sites. An antigen, shown as a sphere with two small triangular cutouts on the bottom, is added and an antigen-antibody complex is formed. This complex has the same structure as the antibody, except that there is are two antigens attached, each one connected at the top of the two bars on each side of the fork.</p>
</aside>
<p class="indent" id="dav_9781319322342_g3mTu1Z0Bk">In many vertebrates, IgG is but one of five classes of immunoglobulins. Each class has a characteristic type of heavy chain, denoted <i class="semantic-i" id="dav_9781319322342_A4eiLmJMnh">α</i>, <i class="semantic-i" id="dav_9781319322342_4lHyYeAlfB">δ</i>, <i class="semantic-i" id="dav_9781319322342_eJqUUDu06E">ε</i>, <i class="semantic-i" id="dav_9781319322342_JMxlDBQGRS">γ</i>, and <i class="semantic-i" id="dav_9781319322342_0WGk3vWovP">μ</i> for IgA, IgD, IgE, IgG, and IgM, respectively. Two types of light chain, <i class="semantic-i" id="dav_9781319322342_1ekAFqeTXH">κ</i> and <i class="semantic-i" id="dav_9781319322342_sifj8RnVvW">λ</i>, occur in all classes of immunoglobulins. The overall structures of <dfn class="keyword" epub:type="keyword" id="dav_9781319322342_Yt4WaRDFqZ">IgD</dfn> and <dfn class="keyword" epub:type="keyword" id="dav_9781319322342_hF5Rc42wgM">IgE</dfn> are similar to that of IgG. <dfn class="keyword" epub:type="keyword" id="dav_9781319322342_WwiJ0ihXLM">IgM</dfn> occurs either in a monomeric, membrane-bound form or in a secreted form that is a cross-linked pentamer of this basic structure (<strong class="important" id="dav_9781319322342_HAt9q7KXZn"><a class="crossref" href="nel_9781319228002_ch05_03.xhtml#dav_9781319322342_agueSgLw0E" id="dav_9781319322342_n82x0mMXGE">Fig. 5-22</a></strong>). <dfn class="keyword" epub:type="keyword" id="dav_9781319322342_pqfiz2LUws">IgA</dfn>, found principally in secretions such as saliva, tears, and milk, can be a monomer, a dimer, or a trimer. IgM is the first antibody to be made by B lymphocytes and the major antibody in the early stages of a primary immune response. Some B cells soon begin to produce IgD (with the same antigen-binding site as the IgM produced by the same cell), but the particular function of IgD is less clear.</p>
<figure class="figure lm_img_lightbox num c3 main-flow" id="dav_9781319322342_agueSgLw0E">
<img alt="A figure shows the pentamer structure of I g M." aria-describedby="dav_9781319322342_w8qYZwMJKx" class="figure" id="dav_9781319322342_UE7sYo3lid" src="../images/nelsonlehnpob8e_05_22_288594.png"/>
<figcaption id="dav_9781319322342_5UQHXQVK9Y">
<p class="noindent" id="dav_9781319322342_Wp17NHeoek"><span class="label" epub:type="label" id="dav_9781319322342_aQwCjkTmUL">FIGURE </span><span class="ordinal" epub:type="ordinal" id="dav_9781319322342_y0cSWQZnQC">5-22 </span><span class="title" id="dav_9781319322342_UBWCi4cAfR">IgM pentamer of immunoglobulin units. </span>The pentamer is cross-linked with disulfide bonds (yellow). The J chain is a polypeptide of <span class="math" id="dav_9781319322342_JeGxCPXNXc" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><mrow><msub><mi>M</mi><mtext>r</mtext></msub></mrow></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper M Subscript r" src="../images/MATH/nel_9781319228002_ch05_03EQ_0015.png"/></annotation-xml></semantics></math></span> 20,000 found in both IgA and IgM.</p>
</figcaption>
</figure>
<aside class="hidden" id="dav_9781319322342_w8qYZwMJKx" title="hidden">
<p class="noindent" id="dav_9781319322342_hq7c09tuTP">The structure has five similar structures that all extend out from the center, forming a roughly circular shape. Each of these is a Y-shaped structure with two strands labeled mu heavy chains that run parallel and then separate to left and right to form a fork before each ends. Where they separate, two horizontal bands connect the halves. To either side of this region, two bands labeled light chains extend out (one to the left and one to the right), and each angles slightly downward to join with a long bar that runs parallel to the forked portion of the heavy chain bars. Two parallel yellow bars connect the bases of each pair of heavy chains except for the pair at the bottom. These are connected to the forks on either side by a single yellow bar and by a horizontal J chain bar in the center of the structure that is connected to the base of the bottom heavy chain bars by two short vertical bars.</p>
</aside>
<p class="indent" id="dav_9781319322342_ITHCBTUfPH">The IgG described above is the major antibody in secondary immune responses, which are initiated by a class of B cells called memory B cells. As part of the organism’s ongoing immunity to antigens already encountered and dealt with, IgG is the most abundant immunoglobulin in the blood. When IgG binds to an invading bacterium or virus, it activates certain leukocytes such as macrophages to engulf and destroy the invader, and it also activates some other parts of the immune response. Receptors on the macrophage surface recognize and bind the Fc region of IgG. When these Fc receptors bind an <span aria-label="167" epub:type="pagebreak" id="page167" role="doc-pagebreak"/>antibody-pathogen complex, the macrophage engulfs the complex by phagocytosis (<strong class="important" id="dav_9781319322342_sM0eFlKydm"><a class="crossref" href="nel_9781319228002_ch05_03.xhtml#dav_9781319322342_W3tH4d1nWF" id="dav_9781319322342_R3qi9SH373">Fig. 5-23</a></strong>).</p>
<figure class="figure lm_img_lightbox num c3 main-flow" id="dav_9781319322342_W3tH4d1nWF">
<img alt="A figure shows phagocytosis of an antibody-bound virus after an I g G-coated virus binds to an F c receptor of a macrophage." aria-describedby="dav_9781319322342_NIkFTBSiXN" class="figure" id="dav_9781319322342_b7tDE50t7e" src="../images/nelsonlehnpob8e_05_23_288595.png"/>
<figcaption id="dav_9781319322342_YuQ7xf3Z3i">
<p class="noindent" id="dav_9781319322342_MqHmkZSSJ1"><span class="label" epub:type="label" id="dav_9781319322342_UXb7Kj9meE">FIGURE </span><span class="ordinal" epub:type="ordinal" id="dav_9781319322342_sNwtE2MWKp">5-23 </span><span class="title" id="dav_9781319322342_KCUdsk0HSe">Phagocytosis of an antibody-bound virus by a macrophage. </span>The Fc regions of antibodies bound to the virus now bind to Fc receptors on the surface of a macrophage, triggering the macrophage to engulf and destroy the virus.</p>
</figcaption>
</figure>
<aside class="hidden" id="dav_9781319322342_NIkFTBSiXN" title="hidden">
<p class="noindent" id="dav_9781319322342_GgkYqzuOhS">An irregular circle on the left is labeled, macrophage. It has small spheres, F c receptors, along its outer surface. One F c receptor is attached to the vertex of a triangle that has its base along one side of a hexagonal viral structure with an S-shaped strand inside. Three other similar triangles are on other sides of the virus. The virus is labeled I g G coated virus and the vertex of a triangle that is not attached at its apex is labeled F c region of I g G. An arrow labeled, phagocytosis points to a second macrophage that is similar to the first except that it has an invagination that contains the virus on all sides except for a narrow opening at the top. Each triangle vertex of the virus is now bonded to an F c receptor.</p>
</aside>
<p class="indent" id="dav_9781319322342_NvHURSCxfZ"><img alt="" aria-hidden="true" class="decorative size-large" id="dav_9781319322342_T14zqj3q9D" role="presentation" src="../images/nelsonlehnpob8e_02_un01_PG056eps.png"/> IgE plays an important role in the allergic response, interacting with basophils (phagocytic leukocytes) in the blood and with histamine-secreting cells called mast cells, which are widely distributed in tissues. This immunoglobulin binds, through its Fc region, to special Fc receptors on the basophils or mast cells. In this form, IgE serves as a receptor for antigen. If antigen is bound, the cells are induced to secrete histamine and other biologically active amines that cause the dilation and increased permeability of blood vessels. These effects on the blood vessels are thought to facilitate the movement of immune system cells and proteins to sites of inflammation. They also produce the symptoms normally associated with allergies. Pollen and other allergens are recognized as foreign, triggering an immune response normally reserved for pathogens. <img alt="" aria-hidden="true" class="decorative size-large inline" id="dav_9781319322342_J3yxi4Rvnt" role="presentation" src="../images/nelsonlehnpob8e_01_pg36.png"/></p>
</section>
<section class="sect2" id="dav_9781319322342_qL0A1RAZoB">
<header id="dav_9781319322342_zUDxteLl8H"><h4 class="b-head v3" id="dav_9781319322342_6EfeIjwKbm">Antibodies Bind Tightly and Specifically to Antigen</h4></header>
<p class="noindent" id="dav_9781319322342_AGKm9HB489"><img alt="" aria-hidden="true" class="decorative size-large" id="dav_9781319322342_jDC7Eo0ADD" role="presentation" src="../images/nelsonlehnpob8e_PG01b.png"/> The binding specificity of an antibody is determined by the amino acid residues in the variable domains of its heavy and light chains. Some of those residues, particularly those lining the antigen-binding site, are hypervariable — especially likely to differ. Specificity is conferred by chemical complementarity between the antigen and its specific binding site. For example, a binding site with a negatively charged group may bind an antigen with a positive charge in the complementary position. In many instances, complementarity is achieved interactively as the structures of antigen and binding site influence each other as they come closer together. Conformational changes in the antibody and/or the antigen then allow the complementary groups to interact fully. This is an example of induced fit. The complex of a peptide derived from HIV (a model antigen) and an Fab molecule, shown in <strong class="important" id="dav_9781319322342_S6XfWm6mrh"><a class="crossref" href="nel_9781319228002_ch05_03.xhtml#dav_9781319322342_dhMzX2BH9T" id="dav_9781319322342_UpnBAsJRYm">Figure 5-24</a></strong>, illustrates some of these properties. The changes in structure observed on antigen binding are particularly striking in this example.</p>
<figure class="figure lm_img_lightbox num c4 center" id="dav_9781319322342_dhMzX2BH9T">
<img alt="A three-part figure, a, b, and c, shows how I g G changes shape when an antigen is bound. Part a shows the conformation with no antigen bound, part b shows the conformation with an antigen bound, and part c shows the conformation with an antigen bound and with the antigen shown." aria-describedby="dav_9781319322342_5xdnikontP" class="figure" id="dav_9781319322342_SwH744i4Zn" src="../images/nelsonlehnpob8e_05_24_288596.png"/>
<figcaption id="dav_9781319322342_aOcqOtQB6L">
<p class="noindent" id="dav_9781319322342_fJcQ0aTYSu"><span class="label" epub:type="label" id="dav_9781319322342_kZM7YYiP76">FIGURE </span><span class="ordinal" epub:type="ordinal" id="dav_9781319322342_JerbLYFWk4">5-24 </span><span class="title" id="dav_9781319322342_LAaYeJUqHt">Induced fit in the binding of an antigen to IgG. </span>The Fab fragment of an IgG molecule is shown here with the surface contour colored to represent hydrophobicity. Hydrophobic surfaces are yellow and hydrophilic surfaces are blue, with shades of blue to green to yellow in between. (a) View of the Fab fragment in the absence of antigen (a small peptide derived from HIV), looking down on the antigen binding site. (b) The same view, but with the Fab fragment in the “bound” conformation with the antigen omitted to provide an unobstructed view of the altered binding site. Note how the hydrophobic binding cavity has enlarged and several groups have shifted position. (c) The same view as (b) but with the antigen (red) in the binding site. [Data from (a) PDB ID 1GGC, R. L. Stanfield et al., <i class="semantic-i" id="dav_9781319322342_LUM4CLCE1p">Structure</i> 1:83, 1993; (b, c) PDB ID 1GGI, J. M. Rini et al., <i class="semantic-i" id="dav_9781319322342_LA3ABARAFB">Proc. Natl. Acad. Sci. USA</i> 90:6325, 1993.]</p>
</figcaption>
</figure>
<aside class="hidden" id="dav_9781319322342_5xdnikontP" title="hidden">
<p class="noindent" id="dav_9781319322342_ErHdUp1W9z">Part a is labeled, conformation with no antigen bound and shows a roughly spherical structure with a U-shaped opening at its bottom and a vertical channel running vertically along its center line. It is mostly green with a few bits of yellow, mostly near the bottom, and a few bits of blue, mostly near the top. Part b is labeled, antigen bound (but not shown). It has a wider, deeper region in the center with more yellow. Part c, antigen bound (shown), has an antigen in the central channel. The antigen has a rectangular lower portion with three protrusions extending from its top half.</p>
</aside>
<p class="indent" id="dav_9781319322342_WAuvSK6aWe">A typical antibody-antigen interaction is quite strong, characterized by <span class="math" id="dav_9781319322342_rTlGXOgYmS" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mi>K</mi><mtext>d</mtext></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper K Subscript d" src="../images/MATH/nel_9781319228002_ch05_03EQ_0016.png"/></annotation-xml></semantics></math></span> values as low as <span class="math" id="dav_9781319322342_XOLMlUsqfM" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mrow><mn>10</mn></mrow><mrow><mo>−</mo><mn>10</mn></mrow></msup><mtext> </mtext><mtext mathsize="0.7em">M</mtext></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="10 Superscript negative 10 Baseline upper M" src="../images/MATH/nel_9781319228002_ch05_03EQ_0017.png"/></annotation-xml></semantics></math></span> (recall that a lower <span class="math" id="dav_9781319322342_8v1Ff5Ci57" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mi>K</mi><mtext>d</mtext></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper K Subscript d" src="../images/MATH/nel_9781319228002_ch05_03EQ_0018.png"/></annotation-xml></semantics></math></span> corresponds to a stronger binding interaction; see <a class="crossref" href="nel_9781319228002_ch05_02.xhtml#dav_9781319322342_VkJf8eCsAa" id="dav_9781319322342_NN1PXkFBPG">Table 5-1</a>). The <span class="math" id="dav_9781319322342_JDaQcHoiJy" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><mrow><msub><mi>K</mi><mtext>d</mtext></msub></mrow></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper K Subscript d" src="../images/MATH/nel_9781319228002_ch05_03EQ_0019.png"/></annotation-xml></semantics></math></span> reflects the energy derived from the hydrophobic effect and the various ionic, hydrogen-bonding, and van der Waals interactions that stabilize the binding. The binding energy required to produce a <span class="math" id="dav_9781319322342_SguKFwsf1s" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><mrow><msub><mi>K</mi><mtext>d</mtext></msub></mrow></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper K Subscript d" src="../images/MATH/nel_9781319228002_ch05_03EQ_0020.png"/></annotation-xml></semantics></math></span> of <span class="math" id="dav_9781319322342_LxtOEJnwoA" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mrow><mn>10</mn></mrow><mrow><mo>−</mo><mn>10</mn></mrow></msup><mtext> </mtext><mtext mathsize="0.7em">M</mtext></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="10 Superscript negative 10 Baseline upper M" src="../images/MATH/nel_9781319228002_ch05_03EQ_0021.png"/></annotation-xml></semantics></math></span> is about 65 kJ/mol.</p>
</section>
<section class="sect2" id="dav_9781319322342_Ora8D5UK37">
<header id="dav_9781319322342_gU86P7SRJ0"><h4 class="b-head v3" id="dav_9781319322342_s0aWvLJVM2">The Antibody-Antigen Interaction Is the Basis for a Variety of Important Analytical Procedures</h4></header>
<p class="noindent" id="dav_9781319322342_TstJj0FWGa">The extraordinary binding affinity and specificity of antibodies make them valuable analytical reagents. Two types of antibody preparations are in use: polyclonal and monoclonal. <dfn class="keyword" epub:type="keyword" id="dav_9781319322342_bhMtMqYXy6"><a class="glossref" epub:type="glossref" href="nel_9781319228002_EM_glossary.xhtml#dav_9781319322342_24JaYz41qq" id="dav_9781319322342_q6nYIoQNdr" role="doc-glossref">Polyclonal antibodies</a></dfn> are those produced by many different B lymphocytes responding to one antigen, such as a protein injected into an animal. Cells in the population of B lymphocytes produce antibodies that bind specific, different epitopes within the antigen. Thus, polyclonal preparations contain a mixture of antibodies that recognize different parts of the protein. <dfn class="keyword" epub:type="keyword" id="dav_9781319322342_WyxANo1Zmp"><a class="glossref" epub:type="glossref" href="nel_9781319228002_EM_glossary.xhtml#dav_9781319322342_g0jE9DROUx" id="dav_9781319322342_2wK9oKNhKF" role="doc-glossref">Monoclonal antibodies</a></dfn>, in contrast, are synthesized by a population of identical B cells (a <dfn class="keyword" epub:type="keyword" id="dav_9781319322342_mlXfbnE4Bv">clone</dfn>) grown in cell culture. These antibodies are homogeneous, all recognizing the same epitope.</p>
<p class="indent" id="dav_9781319322342_JriONckLfX">The specificity of antibodies has practical uses. In a versatile analytical technique, an antibody is attached to a reagent that makes it easy to detect (<strong class="important" id="dav_9781319322342_YyaJEuVN9x"><a class="crossref" href="nel_9781319228002_ch05_03.xhtml#dav_9781319322342_nCliKyOmIN" id="dav_9781319322342_a9D8FabSY0">Fig. 5-25</a></strong>). When the antibody binds the target protein, the label reveals the presence of the protein in a solution or its location in a gel, or even in a living cell (<a class="crossref" href="nel_9781319228002_ch05_03.xhtml#dav_9781319322342_nCliKyOmIN" id="dav_9781319322342_jwYrfbNvVM">Fig. 5-25a</a>). In one application of this technique, an <dfn class="keyword" epub:type="keyword" id="dav_9781319322342_0BBmgnLNbh"><a class="glossref" epub:type="glossref" href="nel_9781319228002_EM_glossary.xhtml#dav_9781319322342_j7kp1IbT9e" id="dav_9781319322342_1rvDUaoKJd" role="doc-glossref">immunoblot</a></dfn> or <dfn class="keyword" epub:type="keyword" id="dav_9781319322342_B1mPe2aj42"><a class="glossref" epub:type="glossref" href="nel_9781319228002_EM_glossary.xhtml#dav_9781319322342_KUwSHZ1rTR" id="dav_9781319322342_g0sX798QsR" role="doc-glossref">Western blot</a></dfn> assay (<a class="crossref" href="nel_9781319228002_ch05_04.xhtml#dav_9781319322342_T7vme6rLWy" id="dav_9781319322342_ZXghysBU6F">Fig. 5-26b</a>), proteins that have been separated by gel electrophoresis are transferred electrophoretically to a nitrocellulose membrane. <span aria-label="168" epub:type="pagebreak" id="page168" role="doc-pagebreak"/>After washing, the membrane is treated successively with primary antibody, secondary antibody linked to enzyme, and substrate. A colored precipitate forms only along the band containing the protein of interest. Immunoblotting allows the detection of a minor component in a sample and provides an approximation of its molecular weight.</p>
<figure class="figure lm_img_lightbox num c4 center" id="dav_9781319322342_nCliKyOmIN">
<img alt="A two-part figure, a and b, shows the use of antibodies as analytical reagents. Part a is a schematic drawing showing how an antibody binds to an antigen in a sample and part b shows an S D S gel that can be used to produce an immunoblot that can be probed to identify protein kinase." aria-describedby="dav_9781319322342_yNZUsx12W0" class="figure" id="dav_9781319322342_N1jIBBz86l" src="../images/nelsonlehnpob8e_05_25ab_288597.png"/>
<figcaption id="dav_9781319322342_C7SsOdlFQl">
<p class="noindent" id="dav_9781319322342_1PNZfdeJM8"><span class="label" epub:type="label" id="dav_9781319322342_UlHeDxe7gw">FIGURE </span><span class="ordinal" epub:type="ordinal" id="dav_9781319322342_t3okDPkt37">5-25 </span><span class="title" id="dav_9781319322342_NJ5XmxOT2X">Antibodies as analytical reagents. </span>(a) A schematic representation of the use of the specific reaction of an antibody with its antigen to identify and quantify a specific protein in a complex sample. (b) One common application is the immunoblot. Lanes 1 to 3 are from an SDS gel; samples from successive stages in the purification of a protein kinase were separated and stained with Coomassie blue. Lanes 4 to 6 show the same samples, but these were electrophoretically transferred to a nitrocellulose membrane after separation on an SDS gel. The membrane was then “probed” with antibody against the protein kinase. The numbers between the SDS gel and the immunoblot indicate <span class="math" id="dav_9781319322342_WpVx1Q0eoQ" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><mrow><msub><mi>M</mi><mtext>r</mtext></msub></mrow></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper M Subscript r" src="../images/MATH/nel_9781319228002_ch05_03EQ_0022.png"/></annotation-xml></semantics></math></span> in thousands.</p>
</figcaption>
</figure>
<aside class="hidden" id="dav_9781319322342_yNZUsx12W0" title="hidden">
<p class="noindent" id="dav_9781319322342_tlfeVKQkrF">Part a has a series of steps on the left. Each has text and symbols. Step 1: Coat surface with sample (antigens). The symbols are three rectangles that each have a different shape across the top (a triangular cutout, a rounded protrusion, and a square cutout). Step 2: Block unoccupied sites with nonspecific protein (a rectangle with a rounded top). Step 3: Incubate with primary antibody against specific antigen (an inverted red Y shape with triangular cutouts at the end of each fork). Step 4: Incubate with secondary antibody-enzyme complex that binds primary antibody (an inverted green Y shape with a small circle with a cutout attached by a stalk to its base). Step 5: Add substrate (a white triangle with one rounded side). Step 6: Formation of colored product indicates presence of specific antigen (three squares). On the right, a figure shows a horizontal row of the nonspecific proteins (rectangles with rounded tops like tombstones). Interspersed with these are a rectangle with a triangular cutout on top, a rectangle with a rounded protrusion, and a rectangle with a square cutout. An inverted red Y shape has fitted one fork onto the rounded protrusion of one of the rectangles in the horizontal line across the bottom. An inverted green Y shape has a square protrusion that fits into the base of the red Y shape to attach them together. The circle with a cutout attached to the base of the green Y binds to substrate molecules, which fit into its cutout, and produces product (small squares). Part b shows two vertical rectangles, an S D S gel on the left and an immunoblot on the right. The gel has three lanes numbered 1, 2, and 3 and the immunoblot has three lanes numbered 4, 5, and 6. Between the two, horizontal lines are labeled from top to bottom as 97.4, 66.2, 45.0, 31.0, 21.5, and 14.4. Lane 1 has many horizontal lines close together from the top until below 31.0. Lane 2 has many bands between 97.4 and 45.0, with the darkest bands near 45.0, and a single band below 31.0 in line with the last band of lane 1. Lane 3 has a thick band adjacent to the thickest band of lane 2 just below 66.2. Lanes 4, 5, and 6 all have a single band in the same location just below 66.2. Lane 4 is slightly lighter than the other two.</p>
</aside>
<p class="indent" id="dav_9781319322342_iUESaEHqTn">We will encounter other aspects of antibodies in later chapters. They are extremely important in medicine and can tell us much about the structure of proteins and the action of genes.</p>
</section>
<section class="summary" id="dav_9781319322342_pFEN9zjL5o">
<header id="dav_9781319322342_6mxC4bJgcQ"><h4 class="title v3" epub:type="title" id="dav_9781319322342_zfmi7dJGjn">SUMMARY 5.2 <i class="semantic-i" id="dav_9781319322342_qaJ9ang2FW">Complementary Interactions between Proteins and Ligands: The Immune System and Immunoglobulins</i></h4></header>
<ul class="ul-no-mark" id="dav_9781319322342_1FPC9wXBoy">
<li id="dav_9781319322342_u0NCnJTWfv"><img alt="" aria-hidden="true" class="decorative size-large" id="dav_9781319322342_qd1hywdY2h" role="presentation" src="../images/nelsonlehnpob8e_PG10.png"/> The immune response is mediated by interactions among an array of specialized leukocytes and their associated proteins. T lymphocytes produce T-cell receptors. B lymphocytes produce immunoglobulins.</li>
<li id="dav_9781319322342_vgbQpt0jJa"><img alt="" aria-hidden="true" class="decorative size-large" id="dav_9781319322342_QHSlt0WGl0" role="presentation" src="../images/nelsonlehnpob8e_PG10.png"/> Humans have five classes of immunoglobulins, each with different biological functions. The most abundant class is IgG, a Y-shaped protein with two heavy chains <span aria-label="169" epub:type="pagebreak" id="page169" role="doc-pagebreak"/>and two light chains. The domains near the upper ends of the Y are hypervariable within the broad population of IgGs and form two antigen-binding sites.</li>
<li id="dav_9781319322342_3UnK5oe7Ec"><img alt="" aria-hidden="true" class="decorative size-large" id="dav_9781319322342_Ty9HDNpxNu" role="presentation" src="../images/nelsonlehnpob8e_PG10.png"/> A given immunoglobulin generally binds to only a part, called the epitope, of a large antigen. Binding often involves a conformational change in the IgG, an induced fit to the antigen.</li>
<li id="dav_9781319322342_i9MEejUfo7"><img alt="" aria-hidden="true" class="decorative size-large" id="dav_9781319322342_96dBNat0kB" role="presentation" src="../images/nelsonlehnpob8e_PG10.png"/> The exquisite binding specificity of immunoglobulins is exploited in analytical techniques such as immunoblotting.</li>
</ul>
</section>
</section>
</body>
</html>